| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 7,850 | $30 | $266.9K |
| J3111 | Injection, romosozumab-aqqg, 1 mg | 14,280 | $10 | $114.2K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 10,350 | $10 | $103.5K |
| J0897 | Injection, denosumab, 1 mg | 3,660 | $20 | $65.9K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 540 | $90 | $48.8K |
| Q5121 | Injection, infliximab-axxq, biosimilar, (avsola), 10 mg | 1,480 | $20 | $32.6K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 150 | $110 | $15.4K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 230 | $50 | $12.2K |
| 96401 | The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient. | 70 | $60 | $4.2K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 50 | $60 | $3K |